lysophosphatidic acid has been researched along with Carcinoma, Anaplastic in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (64.29) | 29.6817 |
2010's | 5 (35.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Catane, LJ; Davidson, B; Hetland Falkenthal, TE; Onallah, H; Reich, R; Tropé, CG | 1 |
Liao, Y; Mu, G; Yu, H; Zhang, J; Zhang, L; Zhou, W | 1 |
Dawson, CW; Ibrahim, MH; Khoo, AS; Lee, HM; Murray, PG; Paterson, IC; Rajadurai, P; Taylor, GS; Thavaraj, S; Tsao, SW; Velapasamy, S; Vrzalikova, K; Wei, W; Yap, LF | 1 |
Aasrum, M; Brusevold, IJ; Christoffersen, T; Sandnes, D; Tveteraas, IH; Ødegård, J | 1 |
Lin, W; Liu, BL; Pan, HL; Zhang, YQ | 1 |
Barbolina, MV; Burkhalter, RJ; Forgacs, G; Hudson, LG; Liu, Y; Marga, F; Moss, NM; Stack, MS; Westfall, SD | 1 |
Hashimoto, K; Kawase, C; Kimura, T; Mabuchi, S; Morishige, K; Ogata, S; Ooyagi, C; Sakata, M; Sawada, K | 1 |
Chung, J; Lipscomb, EA; Mercurio, AM; Yoon, SO | 1 |
Bektas, M; Goparaju, S; Liu, H; Milstien, S; Payne, SG; Spiegel, S | 1 |
Hanousek, L; Sedlákova, I; Tosner, J; Vávrová, J | 1 |
Calluzzo, N; Fishman, DA; Smicun, Y; Wang, FQ | 1 |
Devine, K; Fishman, DA; Gil, O; Smicun, Y | 1 |
Brindley, DN; Hurst-Kennedy, J; Murph, MM; Newton, V; Radhakrishna, H | 1 |
George, SP; Guo, H; Khurana, S; Mathew, S; Siddiqui, MR; Tigyi, G; Tomar, A; Wang, Y | 1 |
1 review(s) available for lysophosphatidic acid and Carcinoma, Anaplastic
Article | Year |
---|---|
Microenvironmental regulation of ovarian cancer metastasis.
Topics: Ascites; Cadherins; Carcinoma; Cell Adhesion; Cell Dedifferentiation; Cell Differentiation; Cell Transformation, Neoplastic; Cytokines; Epithelial Cells; Extracellular Matrix; Female; Fibroblasts; Humans; Inflammation; Integrins; Intercellular Signaling Peptides and Proteins; Lysophospholipids; Neoplasm Proteins; Ovarian Neoplasms; Peptide Hydrolases; Peritoneal Neoplasms; Phenotype | 2009 |
13 other study(ies) available for lysophosphatidic acid and Carcinoma, Anaplastic
Article | Year |
---|---|
Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma; Disease-Free Survival; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Kaplan-Meier Estimate; Lysophospholipids; Middle Aged; Multivariate Analysis; Neoplasm Grading; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Phosphoric Diester Hydrolases; Phosphorylation; Proportional Hazards Models; Proto-Oncogene Proteins c-akt; Receptors, Lysophosphatidic Acid; Risk Factors; RNA, Messenger; Signal Transduction; Time Factors; Treatment Outcome | 2018 |
Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.
Topics: Carcinoma; Cell Line, Tumor; Cell Movement; Enzyme Activation; Focal Adhesion Protein-Tyrosine Kinases; Humans; Lysophospholipids; Pancreatic Neoplasms; Paxillin; Receptors, Lysophosphatidic Acid; RNA, Messenger | 2013 |
Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinoma.
Topics: Adenocarcinoma; Carcinoma; Cell Line, Tumor; Cell Movement; Down-Regulation; Epstein-Barr Virus Infections; Gene Expression Regulation, Neoplastic; Herpesvirus 4, Human; Humans; Lysophospholipids; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phosphoric Diester Hydrolases; Receptors, Lysophosphatidic Acid; Signal Transduction; T-Lymphocytes, Cytotoxic; Viral Matrix Proteins | 2015 |
Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells.
Topics: Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; DNA; ErbB Receptors; Gefitinib; HCT116 Cells; HT29 Cells; Humans; Lysophospholipids; Pancreatic Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Transcriptional Activation | 2016 |
Modulation of Nav1.8 by Lysophosphatidic Acid in the Induction of Bone Cancer Pain.
Topics: Animals; Biophysics; Bone Neoplasms; Cancer Pain; Carcinoma; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Female; Ganglia, Spinal; Gene Expression Regulation, Neoplastic; Hyperalgesia; Isoxazoles; Lysophospholipids; Membrane Potentials; NAV1.8 Voltage-Gated Sodium Channel; Neurons; Pain Measurement; Patch-Clamp Techniques; Propionates; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid | 2016 |
Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antineoplastic Agents; Carcinoma; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Lysophospholipids; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Ovarian Neoplasms; rho-Associated Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2009 |
The Met receptor and alpha 6 beta 4 integrin can function independently to promote carcinoma invasion.
Topics: 3T3 Cells; Animals; Carcinoma; Cell Line, Tumor; Culture Media, Conditioned; Hepatocyte Growth Factor; Humans; Immunoblotting; Integrin alpha6beta4; Integrin beta4; Lysophospholipids; Mice; Neoplasm Invasiveness; Precipitin Tests; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Receptors, Growth Factor; Retroviridae; RNA Interference; RNA, Small Interfering; Time Factors | 2004 |
A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells.
Topics: Animals; Carcinoma; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Diglycerides; Down-Regulation; ErbB Receptors; Glycerides; Humans; Lysophospholipids; Male; Mice; Mitochondria; Mitogen-Activated Protein Kinase 3; NIH 3T3 Cells; Phosphatidic Acids; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Rats; S Phase; Transcriptional Activation; Up-Regulation | 2005 |
[Lysophosphatidic acid in ovarian cancer patients].
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma; Female; Humans; Lysophospholipids; Middle Aged; Ovarian Neoplasms | 2006 |
Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion.
Topics: Carcinoma; Female; Humans; Lysophospholipids; Matrix Metalloproteinase 7; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Ovarian Neoplasms; Receptors, Lysophosphatidic Acid; RNA Interference; RNA, Small Interfering; Tumor Cells, Cultured | 2006 |
S1P and LPA have an attachment-dependent regulatory effect on invasion of epithelial ovarian cancer cells.
Topics: Actins; Biocompatible Materials; Blotting, Western; Cadherins; Carcinoma; Cell Adhesion; Cell Line, Tumor; Collagen; Drug Combinations; Extracellular Matrix; Female; Fluorescent Antibody Technique; Focal Adhesion Kinase 1; Humans; Laminin; Lysophospholipids; Neoplasm Invasiveness; Ovarian Neoplasms; Proteoglycans; Sphingosine | 2007 |
Lysophosphatidic acid decreases the nuclear localization and cellular abundance of the p53 tumor suppressor in A549 lung carcinoma cells.
Topics: Apoptosis; Carcinoma; Cell Line, Tumor; Cell Nucleus; DNA Damage; Humans; Lung Neoplasms; Lysophospholipids; Mitogens; Neoplasms; Receptors, Lysophosphatidic Acid; Transcription, Genetic; Tumor Suppressor Protein p53 | 2007 |
Autotaxin and lysophosphatidic acid stimulate intestinal cell motility by redistribution of the actin modifying protein villin to the developing lamellipodia.
Topics: Actins; Animals; Caco-2 Cells; Carcinoma; Cell Line; Cell Movement; Dogs; Humans; Intestinal Mucosa; Intestinal Neoplasms; Lysophospholipids; Microfilament Proteins; Multienzyme Complexes; Phosphodiesterase I; Phospholipase C gamma; Phosphoric Diester Hydrolases; Phosphorylation; Protein Transport; Pseudopodia; Pyrophosphatases; Receptors, Lysophosphatidic Acid; src-Family Kinases | 2008 |